{"name":"Immunomic Therapeutics, Inc.","slug":"immunomic-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ITI-3000","genericName":"ITI-3000","slug":"iti-3000","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ITI-3000","genericName":"ITI-3000","slug":"iti-3000","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRjd6d2d4Vnl0dlB3Rk1lbXN5NWxqaFljLTlrdGVZX2UtRjBBMnBMdzJwdkV5RUJQalRoNWxFbE5Sek5FZHpuazFhaEliQk5EZzVJQm5UbVhZdEF1bTF6LUtLcWhDRHVuaVJhNVFLNlM5OWdIVV9zX2lfMDEtWG55em1ldGkxNmNQR1Z2Nlo5M0ZfSFk?oc=5","date":"2026-04-08","type":"trial","source":"openPR.com","summary":"Human Papillomavirus Associated Cancer Clinical Trial - openPR.com","headline":"Human Papillomavirus Associated Cancer Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQTVEzVVdBSWhBTXFRY1gxazZqeXRFbkpKdHAyOHNRd3JLMmxPTllESTlvUllfb1plM0VGNnhBcVpTN3lScV82NjZxVnh2RElSbjlPNDVXV0xJNlRaRXhpMlY4RVd5YlVqRk5HUTZJUVdTdVdSaFhFN09HSkpZRW5JdjJ0QkFqZGZjcHZnejkzNUhBWW0zaEtScVZmVENiazByaXFTTzBjeERUSVVlNl9vajlNX0pxaWRQM2xTclFlWVNwTmpONWxjbGoyZEV1bWp0Nlczc0NOTG9VTDRDYkpubjhuSGdMQXhRNHFtNllHQWhPN3dmQm5INmxad1gwLU9XNENfR2tFVVpDNzNyZDFZNDRzU1JuNS0zYWp0dmFaekh5UXc2?oc=5","date":"2026-02-04","type":"regulatory","source":"PR Newswire UK","summary":"Food Allergy Market Forecast to Reach USD 73.2 Billion by 2035 as Diagnostics, Labeling Compliance, and Immunotherapy Expand Clinical Pathways - PR Newswire UK","headline":"Food Allergy Market Forecast to Reach USD 73.2 Billion by 2035 as Diagnostics, Labeling Compliance, and Immunotherapy Ex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPc1pjaFNNQU1iaW15aXl5Wk5yU3dRZWdHUDBsZFFVQlFVQXpQOG1pZFMyejh3aXZySGwtVmpfVm91WnhxbGEzVF9nWExuX3ZkbF9oaENndDA0bVprd0pQYktXSlJ6YmlCWXNzd0JMMFB4Ul9YMWlrTW1Zb3FMcGNmS0h1RnNsaDYwOXBudlpHaER3aTdlSFJwekYxdGtwbU82ZHhYWXVSWGQ1WFJ1bl94R2x5ZUU2Qm1SeEZla3VOUEhMb2o4dllEX3VOVFl3UmFzQkxvWlhGYWd2THZGdWdfckcyM3lTeFdScFlOQlJ4Q19lTll5cm9fSWJfQQ?oc=5","date":"2026-01-29","type":"pipeline","source":"globenewswire.com","summary":"Elevar Therapeutics Names Dong-Gun Kim CEO as It Focuses on Post-NDA Commercialization Strategy - globenewswire.com","headline":"Elevar Therapeutics Names Dong-Gun Kim CEO as It Focuses on Post-NDA Commercialization Strategy","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-20","type":"regulatory","source":"Business Wire","summary":"Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer, to Be Studied Alone and in Combination with Keytruda","headline":"Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Tri","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBMbmNGeFo0dk9iWHdNY3N1Zm82cXp0bmlLaVU5UGhWdkhhOS16WE5NWVhlUmJMb04xeE5meWhXai1MRkNDcEpab3Exems4cW9DdkxpR2hWZ3NUV19fWmpURWd1X2JZUFNDbk5iNFBYdTc?oc=5","date":"2025-03-18","type":"pipeline","source":"Labiotech.eu","summary":"The hottest cancer vaccine companies you should know about - Labiotech.eu","headline":"The hottest cancer vaccine companies you should know about","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-01-27","type":"trial","source":"globenewswire.com","summary":"Glioblastoma Market, an Area With High Trial Failure And - globenewswire.com","headline":"Glioblastoma Market, an Area With High Trial Failure And","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQSkhtZ0Iyd1RzRlNycjVYRF9yYVpQdFZpZFFUNm1iczBuSFlWQVFoUTcxMi1sY0lRZkNxc3AwM21hSlBLSFFtNXotaUxvODVadVE4T1JxXzBNZlUzVmtoSnBiV3ZRYi03NW5HMUZzZVZlQWI2bWRvSEFrUXVPeUMzSklkNkRiZ1Vk?oc=5","date":"2024-10-05","type":"pipeline","source":"Grand View Research","summary":"South Korea Food Allergy Market Size & Outlook, 2025-2030 - Grand View Research","headline":"South Korea Food Allergy Market Size & Outlook, 2025-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNazJaQnBlUUdha3U5Ym50U2J4VUdCUkZiZWRyUjEtYlBIaF9zeV83aEQ1R3ViM1J4QmVpdTdlYzNlNW9jdnI4eXZZMzJlNDVoNE0zenlzc1FpWmtHVFNQRVFLM0FwVTZEcTdmdTJWazFmQmxGMzdXOEJXVFQ2cy1jdg?oc=5","date":"2024-09-03","type":"pipeline","source":"Grand View Research","summary":"Japan Food Allergy Market Size & Outlook, 2025-2030 - Grand View Research","headline":"Japan Food Allergy Market Size & Outlook, 2025-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOdVVJX0RoRThCVktyVlRNc1hYVnd3blZza0tabkxXNFR5WHhiWGs4dXBkbEREYzFyRF8xUnR0cTNuS1FTeVE5a2tIVlFZbWQ0QjllcVRSdnFMWkt1eXR4TS1HUEtaMzhqS3NPUVFwbUhUVnN2d3lXWmR5dlRtUjB3a25yWmNONy1Ba052QWY3cGNnTmNfQVlDQjhGaUxxRS10MXBNRQ?oc=5","date":"2024-02-08","type":"pipeline","source":"The Business Journals","summary":"Greater Washington biotech veteran Bill Hearl dies - The Business Journals","headline":"Greater Washington biotech veteran Bill Hearl dies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQM2dTdmpST3ZkYVFZUHdHZDBjNVk2T1FMcHpTcktYUFRYZF9NSGowbzk0VG9udmJTNXNZT3ctakljdTRucFZObWhwa2lrem83UGJpeVU3STFMTFZjZ1BKSi1XZ2tJdUdva2k5S1Q4LWJkWUZNclFzcXNQczNFcm5ZYUQwWFlBRlBhRHE4VTV2WWp5MWlpQ01Xa2xqMm1GUmVFVmM3UDFja0lpZmNFckVhSlBjM0g?oc=5","date":"2022-06-07","type":"pipeline","source":"citybiz","summary":"Immunomic Therapeutics Appoints Brian Stamper to VP, Cell Therapy Operations - citybiz","headline":"Immunomic Therapeutics Appoints Brian Stamper to VP, Cell Therapy Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9NazE5R0V2aGp4LTlJYnhqM0lhN2k0Q216TTdxZUk5UzhhMEtzMTBoT2VHY29NOHNhMWZVUU1BS2JhVy1UQkFRUENiRzNBcVVtT01iQl9jYzBuZjVMZU1HWDZneHc5MmduYVZHSjRkdk9lcEQ1ZjVVRHFrdDN1ajQ?oc=5","date":"2015-10-13","type":"pipeline","source":"Johns Hopkins University","summary":"Vaccine technology developed at Johns Hopkins could lead to treatment for peanut allergies - Johns Hopkins University","headline":"Vaccine technology developed at Johns Hopkins could lead to treatment for peanut allergies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxNT0Y1LW9iS0gwOUlMdDRvanRJb3JBVTlxYm56MWc5TmdkYWk3Wm9mTFJaVlU1bzU4VzlzSlZRYndXZGxDcUk1bDd4UkZ0bm9ySDdoSkpLTkYzOHRCMlVrYnI5R0N0NnkxTHZOeXBHc3RjRjN5ekdqS1VBOUdtdWlNeFVIaWhhdG1XRU9Nei1aVUN5c1ZVZTRTYmUxYTdPSWdQUWFhamVPYVhmY0RhNWFZcFkzeVZnUTVwZXlGeGpOZmtDS0lBZDAzc1lKdDNSR0FwS1RPOUpla2xRQVhMZ2RnM2hzZWhvcGM1TWJZYlhacmtXVjRiX05kR3ZVS0I2RzRYMFE?oc=5","date":"2015-10-09","type":"deal","source":"PR Newswire","summary":"Astellas Pharma and Immunomic Therapeutics Announce Worldwide Partnership for LAMP-vax™ Products for Allergic Disease - PR Newswire","headline":"Astellas Pharma and Immunomic Therapeutics Announce Worldwide Partnership for LAMP-vax™ Products for Allergic Disease","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}